BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$478M |
| 2 |
Apple
AAPL
|
+$347M |
| 3 |
Alibaba
BABA
|
+$295M |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$261M |
| 5 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$995M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$128M |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$112M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$109M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.51% |
| 2 | Financials | 5.78% |
| 3 | Consumer Discretionary | 5.73% |
| 4 | Healthcare | 5.19% |
| 5 | Communication Services | 4.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ENZ
3701
DELISTED
Enzo Biochem, Inc.
ENZ
| $23.9K | ﹤0.01% |
7,103
-2,139
| -23% | -$7.54K |
|
3702
Dianthus Therapeutics
DNTH
$6.07B
| $23.9K | ﹤0.01% |
101
-87
| -46% | -$21.5K |
|
|
CNST
3703
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $23.9K | ﹤0.01% |
1,948
-1,364
| -41% | -$15.2K |
|
3704
First Northwest Bancorp
FNWB
$106M
| $23.9K | ﹤0.01% |
1,470
-472
| -24% | -$7.61K |
|
|
KDMN
3705
DELISTED
Kadmon Holdings, Inc.
KDMN
| $23.9K | ﹤0.01% |
11,583
-9,273
| -44% | -$20.6K |
|
3706
Ooma
OOMA
$578M
| $23.8K | ﹤0.01% |
2,275
-1,693
| -43% | -$21.5K |
|
3707
iShares 3-7 Year Treasury Bond ETF
IEI
$17.7B
| $23.6K | ﹤0.01% |
188
-340
| -64% | -$42K |
|
|
CCXI
3708
DELISTED
ChemoCentryx, Inc.
CCXI
| $23.5K | ﹤0.01% |
2,529
-2,167
| -46% | -$25.1K |
|
|
OSG
3709
DELISTED
Overseas Shipholding Group Inc.
OSG
| $23.5K | ﹤0.01% |
12,506
-896
| -7% | -$1.66K |
|
3710
BGSF Inc
BGSF
$59.2M
| $23.5K | ﹤0.01% |
1,243
-511
| -29% | -$10.4K |
|
|
TECX
3711
Tectonic Therapeutic
TECX
$623M
| $23.5K | ﹤0.01% |
120
-103
| -46% | -$22.2K |
|
|
CASA
3712
DELISTED
Casa Systems, Inc. Common Stock
CASA
| $23.4K | ﹤0.01% |
3,635
-2,578
| -41% | -$18.8K |
|
|
ESSA
3713
DELISTED
ESSA Bancorp
ESSA
| $23.4K | ﹤0.01% |
1,532
-485
| -24% | -$7.46K |
|
|
EFC
3714
Ellington Financial
EFC
$1.75B
| $23.4K | ﹤0.01% |
+1,300
| New | +$23.5K |
|
3715
Esquire Financial Holdings
ESQ
$1.15B
| $23.3K | ﹤0.01% |
926
-346
| -27% | -$8.16K |
|
|
BRT
3716
BRT Apartments
BRT
$265M
| $23.3K | ﹤0.01% |
1,647
-490
| -23% | -$6.69K |
|
|
ASRT
3717
DELISTED
Assertio
ASRT
| $23.1K | ﹤0.01% |
112
-94
| -46% | -$22.4K |
|
|
JAX
3718
DELISTED
J. Alexander's Holdings, Inc.
JAX
| $23.1K | ﹤0.01% |
2,056
-667
| -24% | -$7.16K |
|
3719
Union Bankshares
UNB
$120M
| $22.6K | ﹤0.01% |
610
-230
| -27% | -$8.65K |
|
|
LJPC
3720
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $22.5K | ﹤0.01% |
2,429
-2,034
| -46% | -$15.3K |
|
|
PFNX
3721
DELISTED
Pfenex Inc.
PFNX
| $22.4K | ﹤0.01% |
3,329
-2,708
| -45% | -$17.3K |
|
3722
Cytosorbents Corp
CTSO
$22.6M
| $22.4K | ﹤0.01% |
3,392
-2,801
| -45% | -$19.2K |
|
|
FPRX
3723
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $22.4K | ﹤0.01% |
3,709
-3,619
| -49% | -$34.6K |
|
|
PMBC
3724
DELISTED
Pacific Mercantile Bancorp
PMBC
| $22.3K | ﹤0.01% |
2,706
-588
| -18% | -$4.67K |
|
3725
Evolution Petroleum
EPM
$135M
| $22.3K | ﹤0.01% |
3,120
-2,209
| -41% | -$14.9K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2019 Portfolio in Review
As of Q2 2019, BNP Paribas Financial Markets held 4,663 positions worth $50.2B, up 8.5% from $46.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
BNP Paribas Financial Markets's Q2 2019 filing shows 353 new, 1,075 increased, 2,687 reduced and 125 closed positions. Its largest new stake was Cigna: 315,599 shares worth $49.7M. The largest sale was Invesco QQQ Trust, an estimated $995M.
By sector, the portfolio is most concentrated in Technology at 8.5% of assets, up from 7.6% a quarter earlier, followed by Financials and Consumer Discretionary.
- BNP Paribas Financial Markets's largest Q2 2019 buy was Cigna: 315,599 shares worth $49.7M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q2 2019, an estimated $478M increase.
- BNP Paribas Financial Markets's biggest Q2 2019 reduction was Invesco QQQ Trust, cutting an estimated $995M.
- BNP Paribas Financial Markets fully exited ARRIS International plc Ordinary Shares in Q2 2019, selling an estimated $40.4M.
- BNP Paribas Financial Markets's ten largest holdings make up 16% of its $50.2B portfolio in Q2 2019.
- BNP Paribas Financial Markets opened 353 new positions and closed 125 in Q2 2019.
- BNP Paribas Financial Markets's portfolio value rose 8.5% quarter-over-quarter to $50.2B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2019, filed 30 Jul 2019.